Not applicableUnknownNCT05656079
What this trial is testing
To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study
Who this might be right for
Breast Cancer
Shanghai Pudong Hospital 204